GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mabion SA (FRA:272) » Definitions » Other Liabilities for Insurance Companies

Mabion (FRA:272) Other Liabilities for Insurance Companies


View and export this data going back to 2021. Start your Free Trial

What is Mabion Other Liabilities for Insurance Companies?

Other Liabilities for Insurance Companies only applies to insurance companies.


Mabion (FRA:272) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mabion SA (FRA:272) » Definitions » Other Liabilities for Insurance Companies
Traded in Other Exchanges
Address
ul. Gen. Mariana Langiewicza 60, Konstantynow Lodzki, POL, 95-050
Mabion SA is a Polish biotechnology company focused on developing and launching modern biotechnology drugs based on monoclonal antibody technology. The drugs developed by the company are targeted treatments, characterized by the drug's ability to recognize the factor causing cancer and interact with this factor only. The company is working on the development of its main priority drug, referred to as the MabionCD20 drug. The therapeutic uses of MabionCD20 are for Non-Hodgkin's lymphoma, Leukemia, and Rheumatoid Arthritis.